Advanced Formulation Engineering: Overcoming Physical Chemistry Bottlenecks from Bench to Commercial Scale
PharpleQ solves the formulation challenges that stall molecules during development. We do not rely on trial-and-error; we systematically deconstruct Reference Listed Drugs (RLD) and engineer drug delivery matrices based on solid-state thermodynamics, solute-solvent mechanics, and physical scalability. From conventional solid orals, targeted release pellets, and highly potent oncology compounds (OEB 4/5) to Monoclonal Antibodies (mAbs) and advanced Amorphous Solid Dispersions (ASDs), we map every molecular transformation under a strict Quality by Design (QbD) roadmap.
At PharpleQ, we completely develop as per client's custom needs or client can select the desired product from already developed stage, for further proceedings.
RLD Reverse Engineering & Target Product Blueprint
Every formulation project at PharpleQ begins with the deconstruction of the Reference Listed Drug (RLD) or Innovator product. We define the definitive performance target before running laboratory batches.
Deformulation (Q1/Q2 Matching)
Qualitative & Quantitative Characterization
- Dissecting the innovator matrix to achieve absolute Q1 (same ingredients) and Q2 (same concentrations) matching via selective extraction, spectroscopic profiling, thermal analysis, and chromatographic quantitation.
Excipient Micro-Fingerprinting
- Isolating the specific molecular weight distribution of polymers, substitution patterns of cellulose derivatives, and exact particle fractions of functional additives used in the RLD.
Deriving the Quality Target Product Profile (QTPP)
We establish the definitive target parameters for the generic or novel product based on the RLD performance profile, specifying:
- Dosage form, delivery design, and exact route of administration.
- Target impurity profiles, stability boundaries, and shelf-life conditions across global climatic zones.
- In-vitro dissolution profiles and critical bioequivalence parameters (In-Vivo Cmax, AUC).
Pre-Formulation Fingerprinting & Solid-State Characterization
Once the QTPP is defined, we evaluate the raw Active Pharmaceutical Ingredient (API) and material streams to determine the Critical Material Attributes (CMAs) that govern the formulation's design space.
Comprehensive Solubility & IDR Profiling
pH-Dependent Equilibrium Solubility
- Saturation solubility mapping across the physiological pH range (pH 1.2, 4.5, 6.8, and 7.4) at 37°C using the shake-flask method followed by phase-appropriate HPLC quantification to establish the true Biopharmaceutics Classification System (BCS) framework.
Intrinsic Dissolution Rate (IDR)
- Determining the chemical dissolution kinetics of the pure, unformulated active substance per unit surface area under constant hydrodynamic parameters to isolate solid-state wetting liabilities.
Advanced X-Ray Diffraction (XRD) & Polymorph Phase Tracking
Polymorphic Fingerprinting
- Utilizing Powder X-Ray Diffraction (PXRD) to chart the distinctive d-spacing matrices of crystalline polymorphs, pseudopolymorphs, co-crystals, or amorphous states.
Solid-State Transformation Screening
- Running PXRD concurrently with Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TGA) to ensure that processing stresses (such as milling pressures, high-shear hydration, compaction, or extrusion heat) do not trigger an uncontrolled phase transformation back to an insoluble or unstable crystal habit.
Particle Size Distribution (PSD) & Morphological Evaluation
Laser Diffraction Mapping
- Characterizing precise particle metrics (d10, d50, d90) fractions alongside volume-mean diameters using wet or dry laser diffraction networks.
Flowability & Particle Morphology
- Correlating PSD with bulk/tapped density, Hausner ratios, and Carr’s compressibility index to map the flow and packing properties that dictate uniform die filling and tableting behavior.
Automated API-Excipient Compatibility Arrays
Isothermal Stress Testing (IST)
- Preparing high-stress binary and ternary blends (API + Excipient + 5% Water) maintained at 40°C / 75% RH and 50°C for up to 4 weeks.
Chemical Impurity & Degradation Screen
- Analyzing the stressed blends via stability-indicating HPLC to proactively identify chemical incompatibilities (such as trace peroxide reactions, esterification, transesterification, or Maillard browning caused by reducing sugars).
Advanced Solubilization & Bioavailability Platforms
When conventional direct compression or wet granulation routes fail for highly insoluble compounds (BCS Class II/IV), PharpleQ deploys targeted chemical engineering platforms to alter the active state.
Hot-Melt Extrusion (HME) Platform
Thermodynamic Miscibility Mapping
- Calculating solubility parameters using the Hansen and Hildebrand models, to determine active solubility within polymeric carriers (e.g., Copovidone VA64, Soluplus, Affinisol, Hypromellose Acetate Succinate) before processing.
Thermal Profiling & Processing Windows
- Mapping the processing window between the drug's melting point (Tm) or polymer's glass transition temperature (Tg) and the thermal degradation threshold of all components.
Screw Configuration & Shear Optimization
- Designing modular co-rotating twin-screw profiles with precise zones for feeding, melting, distributive/dispersive mixing (kneading blocks), and degassing to create a single-phase Amorphous Solid Dispersion (ASD) free from degradation.
Spray Drying Technology
Atomization & Solvent System Engineering
- Formulating multi-solvent feed solutions (utilizing acetone, methanol, ethanol, dichloromethane, or water mixtures) balanced for viscosity, surface tension, and solid-loading capacity.
Thermodynamic Drying Kinetics
- Controlling inlet temperature (Tin), outlet temperature (Tout), atomization air pressure, and drying gas flow rates (nitrogen for organic solvents) to adjust the evaporative drying rate, keeping the product below its glass transition temperature to prevent sticky aggregation.
Particle Morphology Engineering
- Optimizing secondary cyclone separation parameters to achieve uniform particle size distribution, low residual volatile levels, and specific particle structures (collapsed, hollow, or corrugated spheres) tailored for direct compaction or inhalation.
Nanoprecipitation & Micro-Milling Systems
Top-Down Wet Media Milling
- Engineering stable nanosuspensions using high-energy planetary or agitator bead mills. We utilize stabilization polymers (HPMC, PVP) and surfactants (SLS, DOSS) to prevent particle crystal growth (Ostwald ripening).
Bottom-Up Nanoprecipitation
- Controlling precipitation by mixing solvent and anti-solvent streams in microfluidic reactors or high-shear mixing zones to consistently yield sub-micron active particles.
Core Unit Operations & Dosage Form Processing Designs
We translate bench-scale active matrices into clear, reproducible unit operations across all delivery platforms, ensuring that the design space accommodates standard manufacturing setups.
Oral Solid Dosages & Oncology Formulations
Granulation Operational Design
- High-Shear Wet Granulation: Mapping impeller torque curves, liquid addition speeds, and wet-massing end-points to achieve uniform granule growth.
- Roller Compaction: Defining screw-to-roll speed ratios, hydraulic pressures (kN/cm), and ribbon density boundaries to minimize uncompacted fines.
Compaction and Compression Mechanics
- Generating tabletability, compressibility, and manufacturability profiles. We evaluate tablet tensile strength against solid fraction and compression force to eliminate capping, lamination, and tool-sticking on high-speed rotary presses.
Multi-Unit Particulate Systems (MUPS)
- Extrusion-spheronization and suspension layering on inert cores (Sugar/MCC spheres), followed by functional polymer coating (Eudragit, HPMCAS, Ethylcellulose) within fluid-bed Wurster systems.
OEB 4/5 High-Containment Processing
- Complete engineering integration for cytotoxic and highly potent oncology compounds. Material handling is conducted within isolated, negative-pressure isolators, evaluating particle drift, static charge generation, and flowability parameters under strict exposure limits (<1 µg/m³).
Monoclonal Antibody (mAb) & Biologic Processing
Sterile Liquid & Pre-Filled Syringe (PFS) Compounding
- Formulating low-shear filling parameters, balancing ionic strength, and adjusting surfactant levels to eliminate bubble-induced oxidation at the air-water interface.
Lyophilization Optimization
- Designing customized freeze-drying recipes by measuring the critical collapse temperature (Tc) and glass transition temperature of the frozen matrix (Tg-prime), optimizing primary and secondary drying intervals.
Liquid, Semi-Solid, & Interindustry Formulations
Structured Suspension Rheology
- Building flocculated networks using targeted zeta-potential adjustments and thixotropic hydrocolloids (Na-CMC, Xanthan Gum, Avicel RC-591) to guarantee long-term physical stability without caking.
Emulsion & Cosmetic Advanced Topicals
- Constructing precise Oil-in-Water (O/W) and Water-in-Oil (W/O) lamellar matrices using high-shear homogenization to achieve stable active entrapment and proper skin absorption.
Veterinary Specialty Dosage Forms
- Engineering high-permeability transdermal pour-ons with volatile/non-volatile carrier systems, along with heavy oral boluses designed for sustained rumen release.
Systematic QbD Implementation: Mapping CMAs to CPPs
Using the data gathered during reverse engineering and pre-formulation, we conduct formal risk assessments to map how Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs) interact to dictate Critical Quality Attributes (CQAs).
DoE Factorial Matrices
- Running fractional and full factorial Design of Experiments (DoE) to mathematically map the processing boundaries.
Excipient Lot-to-Lot Variability Testing
- Intentionally challenging the formulation using excipient batches at the upper and lower specification limits for bulk density, particle size, and moisture content to ensure the design space absorbs normal raw material variations.
Dimensionless Kinematic Scaling
- Using mathematical scaling calculations—including volumetric swept ratios, tip speeds, and dimensionless Froude numbers—to ensure mixing dynamics, shear inputs, and thermal transfer remain consistent when transitioning from laboratory pilot systems to full commercial lines.
Extrusion Specific Mechanical Energy (SME) Scaling
- For HME scale-up, monitoring and maintaining equivalent Specific Mechanical Energy (SME) inputs and residence time distributions (RTD) to prevent under-processing or localized thermal degradation when moving from pilot lines to larger commercial twin-screw extruders.
Packaging Development & Barrier Evaluation
A pharmaceutical formulation is only as stable as the primary barrier enclosure protecting it. Packaging selection runs parallel to our core formulation steps to ensure comprehensive stability.
Moisture & Gas Permeation Engineering
- Quantifying the Water Vapor Transmission Rate (WVTR) and Oxygen Transmission Rate (OTR) of target flexible films and rigid polymer bottles to match the hygroscopicity profile derived during DVS testing.
Laminate Optimization
- Selecting custom blister materials—ranging from economical monolayer PVC and high-performance PVDC structures to high-barrier Alu-Alu (Cold Form Foil) and specialized Aclar® laminates.
Extractable & Leachable (E&L) Risk Mitigation
- Conducting forced extraction studies on elastomeric stoppers, pre-filled syringes, and plastic closures to prevent component migration into sensitive liquid parenterals or oncology solutions.
Container-Closure Integrity Testing (CCIT)
- Performing vacuum decay, dye ingress, and high-voltage leak detection (HVLD) to verify sealing performance across the commercial lifecycle.
Technical Deliverables & Transfer Documentation
- RLD Deformulation & Q1/Q2 Compliance Summary Report
- Master Pre-Formulation Compendium (Solubility, IDR, PXRD, PSD, and IST-Drug-Excipient Compatibility)
- QTPPs, CMAs, and CPPs Criticality Risk Assessment (FMEA Log)
- Design of Experiments (DoE) Design Space Boundary Definitive Analysis
- Primary Packaging Material Compatibility
- Master Batch Formula Card (MBFR)